KALV - KalVista Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5397.38M
Enterprise Value 3299.45M
Trailing P/E N/A
Forward P/E 1-15.16
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)22.03
Price/Book (mrq)3.82
Enterprise Value/Revenue 316.60
Enterprise Value/EBITDA 6-14.11

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr 30, 2018
Most Recent Quarter (mrq)Jan 31, 2019

Profitability

Profit Margin -71.76%
Operating Margin (ttm)-119.33%

Management Effectiveness

Return on Assets (ttm)-13.93%
Return on Equity (ttm)-19.53%

Income Statement

Revenue (ttm)18.04M
Revenue Per Share (ttm)1.34
Quarterly Revenue Growth (yoy)66.90%
Gross Profit (ttm)-9.84M
EBITDA -21.22M
Net Income Avi to Common (ttm)-12.95M
Diluted EPS (ttm)-0.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111.15M
Total Cash Per Share (mrq)6.44
Total Debt (mrq)109k
Total Debt/Equity (mrq)0.10
Current Ratio (mrq)6.59
Book Value Per Share (mrq)6.03

Cash Flow Statement

Operating Cash Flow (ttm)-31.81M
Levered Free Cash Flow (ttm)-23.67M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.82
52-Week Change 3171.07%
S&P500 52-Week Change 34.63%
52 Week High 334.92
52 Week Low 37.73
50-Day Moving Average 325.38
200-Day Moving Average 322.26

Share Statistics

Avg Vol (3 month) 3156.22k
Avg Vol (10 day) 3177.15k
Shares Outstanding 517.25M
Float 8.93M
% Held by Insiders 110.43%
% Held by Institutions 178.57%
Shares Short (Apr 30, 2019) 4621.11k
Short Ratio (Apr 30, 2019) 43.92
Short % of Float (Apr 30, 2019) 49.51%
Short % of Shares Outstanding (Apr 30, 2019) 43.60%
Shares Short (prior month Mar 29, 2019) 4541.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 214/1
Last Split Date 3Nov 22, 2016